All Type of News
Bipolar phenomenon in application for medical residentship.
According to the recruit report of the medical specialists in Korea, the number of applicants for the OB & Gyn. showed the lowest in the OECD nations at less than 60% as a result of ever declining birth rates these da...
5th FTA talks to launch from early today.
The 5th KORUS FTA talks begun from the dawn of today at Korean time with 5 day session at Big Sky, Montana U. S. A.
In the talk they will discuss 16 business areas including drugs, agriculture, service and finance ...
Product approval process to be expedited
The new product approval process, which has been delayed due to the recent generic drugs' bioequivalence test data fabrication, may be facilitated by a newly formed task force team, according to the Korea Food and Dru...
Bio equivalency for 4,113 products being approved.
The bio equivalency for the total 4,113 drugs was approved this year, for which Hanmi and Chongkundang predominated its test.
The KFDA reported that as of Oct. 31 the total 4,113 drugs took the bio test, of ...
GSK holds scientific symposium for Bonviva
GSK said on December 3 that it sponsored its scientific symposium for Bonviva (ibandronate), the first and only once-monthly tablet for the effective treatment of postmenopausal osteoporosis prior to its launching in ...
Prices of cold remedies to rise 20%
The prices of Dong-A's Panpyrin-F and Dongwha's Pancol-A, local popular brands for common cold, are expected to rise by 20 percent next January.
The two companies said on December 4 they plan to raise the prices o...
Prices of 1,397 items to be readjusted from next February
A total of 1,397 drugs covered by national health insurance, including LG Life Sciences's Zanidip (lercarnidipine), will be subject to price readjustment from January 1, next year, the Ministry of Health and Welfare s...
10 Korean companies to join anti-alopecia market
Finasteride-based anti-alopecia preparations will be newly spotlighted in the domestic market, as more than ten generic makers homegrown medicines for hair loss are lining up side by side with MSD Korea's Propecia.
...
Markets for no smoking aids showing big changes.
The no-smoking aid markets shed a restructuring sign amid many market recontracts and other co-marketing activities, which all happened at the same time.
According to a reliable drug distribution circle on Nov. 30,...
Consultative body for clinical trials to convene
A consultative body for clinical trials will convene during this week, according to the Korea Food and Drug Administration.
Composed of representative from academia, industry and the government, the body is aiming ...
